Although dyslipidemia seems to be associated with the risk of development of hypertension [26], and affects PON1 activity in CKD [15,16], there are sparse data on PON1 activity levels in patients with hypertensive nephropathy. The gene discussed is PON1; the disease is metabolic syndrome.